Streetbeat News

Regulatory

TMO

The FDA has approved Thermo Fisher Scientific's immunoassay as the first and only blood-based biomarker test to assess preeclampsia. This approval could lead to increased demand for the company's diagnostic products.

Portfolio Pulse from Benzinga Newsdesk

May 19, 2023 | 12:04 pm

SPY

USO

VGK

Saudi Crown Prince Mohammed bin Salman stated that the kingdom is ready to mediate between Russia and Ukraine to resolve the ongoing conflict. This could potentially stabilize oil prices and impact related ETFs.

Portfolio Pulse from Charles Gross

May 19, 2023 | 11:53 am

MOS

NTR

The G7 draft communique highlights the importance of supporting fertilizer value chains, including local production, in compliance with World Trade Organization (WTO) rules.

Portfolio Pulse from Benzinga Newsdesk

May 19, 2023 | 11:13 am

BNTX

CVAC

PFE

Curevac's motion to transfer patent litigation filed by Pfizer/BioNTech to the Eastern District of Virginia has been granted, potentially accelerating progress with a likely trial date in 2024.

Portfolio Pulse from Benzinga Newsdesk

May 19, 2023 | 11:08 am

ICPT

Intercept Pharmaceuticals' stock trading was halted today as the FDA Advisory Committee reviews Obeticholic Acid, a treatment for pre-cirrhotic fibrosis due to NASH.

Portfolio Pulse from Benzinga Newsdesk

May 19, 2023 | 11:07 am

BJDX

Bluejay Diagnostics plans to modify the clinical trials design for its Symphony IL-6 test to obtain more patient data and evaluate its effectiveness in risk stratifying hospitalized sepsis patients.

Portfolio Pulse from Benzinga Newsdesk

May 19, 2023 | 11:02 am

KYMR

Kymera Therapeutics has dosed its first patient in a Phase 1 oncology trial of MDM2 degrader KT-253, marking a significant milestone in the development of the drug.

Portfolio Pulse from Benzinga Newsdesk

May 19, 2023 | 11:01 am

TSLA

India's Minister of Heavy Industries has stated that Tesla is serious about setting up a production and innovation base in India, which could potentially expand the company's global footprint.

Portfolio Pulse from Benzinga Newsdesk

May 19, 2023 | 11:00 am

ICPT

Intercept Pharmaceuticals' shares have been halted ahead of the FDA AdCom meeting, which will discuss the company's liver disease drug, Ocaliva.

Portfolio Pulse from Benzinga Newsdesk

May 19, 2023 | 10:56 am

FXI

LXEH

China's President Xi proposed to establish meeting and dialogue mechanisms to facilitate cooperation between China and Central Asian countries in various sectors, including industrial development, investment, agriculture, transportation, emergency management, education, and political party affairs.

Portfolio Pulse from Charles Gross

May 19, 2023 | 10:43 am